Increased fructose concentrations in blood and urine in patients with diabetes

Diabetes Care

Volumn 25, Issue 2, 2002, Pages 353-357

  Kawasaki, Takahiro ^a,c   Akanuma, Hiroshi ^b   Yamanouchi, Toshikazu ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCOSE; ION EXCHANGE RESIN;

ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FRUCTOSE METABOLISM; GAS CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION; URINE LEVEL; ADULT; AGED; BLOOD; DIET RESTRICTION; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; URINE;

ADULT; AGED; DIABETES MELLITUS; FASTING; FEMALE; FRUCTOSE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED;

EID: 0036479751     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.2.353     Document Type: Article

References (22)

1. Scriver CR, Beaudet AL, Sly WS, Valle DV: The Metabolic and Molecular Bases of Inherited Disease. Vol. 1, 7th ed. New York, McGraw-Hill, 1995, p. 905-934
2. Lee MK, Miles PDG, Khoursheed M, Gao KM, Moossa AR, Olefsky JM: Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43:1435-1439, 1994
3. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen W: Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 49:1155-1163, 1989
4. Woods HF, Alberti KGMM: Dangers of intravenous fructose. Lancet 23: 1354-1357, 1972
5. McPherson JD, Shilton BH, Wallon DJ: Role of fructose in glycation and cross-linking of proteins. Biochemistry 27:1901-1907, 1988
6. Aloia JF: Monosaccharides and polyols in diabetes mellitus and uremia. J Lab Clin Med 82:809-817, 1973
7. Pitkānen E: Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients. Clin Chim Acta 251:91-103, 1996
8. Yoshii H, Uchino H, Ohmura C, Watanabe K, Tanaka Y, Kawamori R: Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass- spectrometry in type 2 diabetes to assess polyol pathway activity. Diabetes Res Clin Pract 51:115-123, 2001
9. Kruszynska YT, Meyer-Alber A, Wellen N, McIntyre N: Energy expenditure and substrate metabolism after oral fructose in cirrhosis. J Hepatol 19:241-251, 1993
10. Kametani S, Shiga Y, Akanuma H: Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway. Eur J Biochem 242:832-838, 1996
11. Topping DL, Mayer PA: The concentrations of fructose, glucose and lactate in the splanchnic blood vessels of rats absorbing fructose. Nutr Metab 13:331-338, 1971
12. Hayward LD, Angyal SJ: A symmetry rule for the circular dichroism of reducing sugars, and the proportion of carbonyl forms in aqueous solutions thereof. Carbohydr Res 53:13-20, 1977
13. Mendeloff AI, Weichselbaum TE: Role of the human liver in the assimilation of intravenously administered fructose. Metabolism 2:450-458, 1953
14. Craik JD, Elloitt KRF: Transport of D-fructose and D-galactose into isolated rat hepatocytes. Biochem J 192:373-375, 1980
15. Hooper RH, Short AH: The hepatocellar uptake of glucose, galactose and fructose in conscious sheep. J Physiol 264:523-539, 1977
16. Hajduch E, Darakhshan F, Hundal HS: Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes. Diabetologia 41:821-828, 1998
17. Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N: Epalrestat, an aldose reductase inhibitor, reduces the levels of Nepsilon-(carboxymethyl) lysine protein adducts and their precursors in erythrocytes from diabetes patients. Diabetes Care 23:1539-1544, 2000
18. Kashiwagi A, Obata T, Suzaki M, Takagi Y, Kida Y, Ogawa T, Tanaka Y, Asahina T, Ikebuchi M, Saeki Y, Kikkawa R, Shigeta Y: Increase in cardiac muscle fructose content in streptozotocin-induced diabetic rats. Metabolism 41:1041-1046, 1992
19. Poulson R, Boot-Handford RP, Health H: The effects of long-term treatment of streptozotocin-diabetic rats with an aldose reductase inhibitor. Exp Eye Res 37:507-515, 1983
20. Tomlinson DR, Townsend J, Fretten P: Prevention of defective axonal transport in streptozotocin-diabetic rats by treatment with "statil" (ICl 1228436), and aldose reductase inhibitor. Diabetes 34:970-972, 1985
21. Yamanouchi T, Shinohara T, Ogata N, Tachibana Y, Akaoka I, Miyashita H: Common reabsorption system of 1,5-anhydro-D-glucitol, fructose, and mannose in rat renal tubule. Biochim Biophys Acta 1291:89-95, 1996
22. Yamanouchi T, Tachibana Y, Akanuma H, Minoda S, Shinohara T, Moromizato H, Miyashita H, Akaoka I: Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol 263:E268-E273, 1997